-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Xylem, Lowers Price Target to $112

Benzinga·10/05/2026 20:33:19
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and lowers the price target from $138 to $112.